Published in Biochem Cell Biol on February 01, 2005
ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem (2006) 2.08
Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev (2009) 1.88
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry (2007) 1.65
Mutational profile of GNAQQ209 in human tumors. PLoS One (2009) 1.62
NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology (2009) 1.47
Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res (2006) 1.40
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer (2009) 1.27
Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res (2008) 1.20
Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat Res (2007) 1.15
Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective. J Mammary Gland Biol Neoplasia (2010) 1.11
Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene. PLoS One (2012) 1.10
The Sch9 kinase is a chromatin-associated transcriptional activator of osmostress-responsive genes. EMBO J (2007) 1.04
A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J Biol Chem (2010) 1.02
Multiple signals converge on a differentiation MAPK pathway. PLoS Genet (2010) 1.01
RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol (2008) 1.01
Epigenomic regulation of oncogenesis by chromatin remodeling. Oncogene (2016) 0.97
Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol Rev (2014) 0.96
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms. Theranostics (2014) 0.95
Enhanced estrogen-induced proliferation in obese rat endometrium. Am J Obstet Gynecol (2009) 0.92
CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells. J Oncol (2010) 0.91
Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts. J Biol Chem (2010) 0.91
The regulation of Th1 responses by the p38 MAPK. J Immunol (2010) 0.91
PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene (2011) 0.89
Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence. Oncogene (2010) 0.89
Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation. Br J Pharmacol (2008) 0.89
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev (2015) 0.89
An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis. FEBS Lett (2010) 0.89
Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta. Oncogene (2009) 0.88
Heterogeneous nuclear ribonucleoprotein R enhances transcription from the naturally configured c-fos promoter in vitro. J Biol Chem (2009) 0.87
MSK2 inhibits p53 activity in the absence of stress. Sci Signal (2009) 0.87
Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells. PLoS One (2012) 0.86
Identification and expression analysis of ras gene in silkworm, Bombyx mori. PLoS One (2009) 0.85
Polarity proteins as regulators of cell junction complexes: implications for breast cancer. Pharmacol Ther (2013) 0.84
An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. BMC Cancer (2007) 0.83
Altered glucose metabolism in Harvey-ras transformed MCF10A cells. Mol Carcinog (2013) 0.82
Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes. BMC Cancer (2007) 0.81
Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma. BMC Cancer (2013) 0.81
A novel role of HLA class I in the pathology of medulloblastoma. J Transl Med (2009) 0.81
Complexity in cancer biology: is systems biology the answer? Cancer Med (2013) 0.81
Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells. J Oncol (2010) 0.79
uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells. Stem Cell Res (2014) 0.79
Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes. BMC Cancer (2015) 0.79
Leukotriene C(4) prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance. Immunology (2011) 0.78
Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine? World J Gastroenterol (2011) 0.78
Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2. Sci Rep (2015) 0.78
Molecular targets and targeted therapies in bladder cancer management. World J Urol (2008) 0.78
Imbalanced expression of mitogen-activated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma. J Zhejiang Univ Sci B (2011) 0.78
Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides (2014) 0.77
MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells. Biochim Biophys Acta (2014) 0.77
Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochim Biophys Acta (2013) 0.76
Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology (2015) 0.76
Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling. Cell Commun Signal (2016) 0.76
Multiple Effects of a Novel Epothilone Analog on Cellular Processes and Signaling Pathways Regulated by Rac1 GTPase in the Human Breast Cancer Cells. Korean J Physiol Pharmacol (2014) 0.76
Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. PLoS One (2014) 0.76
Mild hypothermia in combination with minimally invasive evacuation of hematoma reduces inflammatory damage in patients via the nuclear factor-κB pathway. Exp Ther Med (2014) 0.75
Phosphorylated Histone 3 at Serine 10 Identifies Activated Spinal Neurons and Contributes to the Development of Tissue Injury-Associated Pain. Sci Rep (2017) 0.75
A new microsphere-based immunoassay for measuring the activity of transcription factors. Biol Proced Online (2010) 0.75
Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats. Biol Res (2016) 0.75
MK3 modulation affects BMI1-dependent and independent cell cycle check-points. PLoS One (2015) 0.75
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion. Oncol Lett (2017) 0.75
p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C. Toxicol Rep (2017) 0.75
Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science (2006) 11.20
Gene regulation by Sp1 and Sp3. Biochem Cell Biol (2004) 2.37
The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat (2010) 2.09
Epigenetic control. J Cell Physiol (2009) 1.85
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics (2012) 1.61
Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods (2003) 1.53
The many roles of the transcriptional regulator CTCF. Biochem Cell Biol (2003) 1.51
Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts. Cancer Res (2002) 1.49
Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res (2010) 1.36
The insulator binding protein CTCF associates with the nuclear matrix. Exp Cell Res (2003) 1.35
H3 phosphorylation: dual role in mitosis and interphase. Biochem Cell Biol (2009) 1.30
Mitotic partitioning of transcription factors. J Cell Biochem (2008) 1.30
Activation and function of immediate-early genes in the nervous system. Biochem Cell Biol (2011) 1.20
The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J Biol Chem (2002) 1.15
Sp1 and Sp3 foci distribution throughout mitosis. J Cell Sci (2006) 1.12
Identification of a direct Dlx homeodomain target in the developing mouse forebrain and retina by optimization of chromatin immunoprecipitation. Nucleic Acids Res (2004) 1.11
Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases. Adv Enzyme Regul (2008) 1.09
Biotin is not a natural histone modification. Biochim Biophys Acta (2009) 1.09
Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28. Oncogene (2005) 1.08
Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression. Cancer Res (2006) 1.05
Differential intranuclear organization of transcription factors Sp1 and Sp3. Mol Biol Cell (2005) 1.05
Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Circ Res (2006) 1.05
Phosphorylated serine 28 of histone H3 is associated with destabilized nucleosomes in transcribed chromatin. Nucleic Acids Res (2007) 1.03
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem Cell Biol (2007) 1.03
Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin. J Biol Chem (2007) 1.02
Phosphorylation of histones by tissue transglutaminase. J Biol Chem (2006) 1.01
Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway. Cancer Res (2006) 0.99
CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins. Biochem Biophys Res Commun (2003) 0.98
Histone modifications as a platform for cancer therapy. J Cell Biochem (2005) 0.95
Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res Treat (2006) 0.94
Targeting class I histone deacetylases in cancer therapy. Expert Opin Ther Targets (2012) 0.93
Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins. Exp Cell Res (2005) 0.93
Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genes. PLoS One (2012) 0.93
Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells. Mol Biol Cell (2010) 0.92
Histone H3 phosphorylation, immediate-early gene expression, and the nucleosomal response: a historical perspective. Biochem Cell Biol (2012) 0.92
Chromatin organization and nuclear microenvironments in cancer cells. J Cell Biochem (2008) 0.92
Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation. Methods (2003) 0.92
Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. J Cell Physiol (2010) 0.92
Immediate early response genes and cell transformation. Pharmacol Ther (2012) 0.92
Mitogen- and stress-activated protein kinase 1 activity and histone h3 phosphorylation in oncogene-transformed mouse fibroblasts. Cancer Res (2004) 0.91
Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts. J Biol Chem (2010) 0.91
Dynamic distribution of HDAC1 and HDAC2 during mitosis: association with F-actin. J Cell Physiol (2013) 0.89
Protein kinase CK2 regulates the dimerization of histone deacetylase 1 (HDAC1) and HDAC2 during mitosis. J Biol Chem (2013) 0.88
Gene expression regulation through 14-3-3 interactions with histones and HDACs. Discov Med (2011) 0.86
Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targets. Arch Immunol Ther Exp (Warsz) (2005) 0.86
Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis. Cancer Metastasis Rev (2013) 0.86
RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing. Nucleic Acids Res (2013) 0.86
The estrogen receptor: more than the average transcription factor. Biochem Cell Biol (2002) 0.85
Pre-mRNA splicing: role of epigenetics and implications in disease. Adv Biol Regul (2012) 0.84
Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells. J Cell Biochem (2002) 0.83
NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor. Genomics (2002) 0.83
Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. Biochem Cell Biol (2007) 0.83
An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. BMC Cancer (2007) 0.83
Increased genomic instability and altered chromosomal protein phosphorylation timing in HRAS-transformed mouse fibroblasts. Genes Chromosomes Cancer (2009) 0.83
The role of Sp1 and Sp3 in the constitutive DPYD gene expression. Biochim Biophys Acta (2006) 0.82
Association of Sp3 and estrogen receptor alpha with the transcriptionally active trefoil factor 1 promoter in MCF-7 breast cancer cells. J Cell Biochem (2008) 0.82
Nucleosomal response, immediate-early gene expression and cell transformation. Adv Enzyme Regul (2009) 0.81
Abnormalities of chromatin in tumor cells. EXS (2006) 0.81
Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction. PLoS One (2013) 0.79
Histone H1(S)-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts. Oncogene (2002) 0.79
Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells. Int J Cancer (2009) 0.79
Current understanding and importance of histone phosphorylation in regulating chromatin biology. Curr Opin Drug Discov Devel (2010) 0.79
Effects of the in vivo supply of butyrate on histone acetylation of cecum in piglets. JPEN J Parenter Enteral Nutr (2007) 0.79
HDAC inhibitors prevent the induction of the immediate-early gene FOSL1, but do not alter the nucleosome response. FEBS Lett (2013) 0.78
Nuclear microenvironments and cancer. J Cell Biochem (2008) 0.78
Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes. Am J Physiol Heart Circ Physiol (2013) 0.76
Yin Yang gene expression ratio signature for lung cancer prognosis. PLoS One (2013) 0.76
Elevated expression of the estrogen receptor prevents the down-regulation of p21Waf1/Cip1 in hormone dependent breast cancer cells. J Cell Biochem (2004) 0.75
Dual cross-linking ribonucleoprotein immunoprecipitation assay. Biochem Cell Biol (2014) 0.75
Carcinoma ex spiradenoma/cylindroma confirmed by immunohistochemical and molecular loss-of-heterozygosity profiling. Am J Dermatopathol (2009) 0.75
Isolation of transcriptionally active chromatin from human breast cancer cells using Sulfolink coupling gel chromatography. J Cell Biochem (2002) 0.75